Oral and extraoral plasmablastic lymphoma: Similarities and differences in clinicopathologic characteristics

American Journal of Clinical Pathology

Volumn 134, Issue 5, 2010, Pages 710-719

  Hansra, Damien ^a   Montague, Naomi ^a   Stefanovic, Alexandra ^a   Akunyili, Ikechukwu ^a   Harzand, Arash ^a   Natkunam, Yasodha ^b   De La Ossa, Margarita ^a   Byrne, Gerald E ^a   Lossos, Izidore S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epstein Barr virus; HIV; Lymphoma; Plasmablastic lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HYDROXYUREA; INTERFERON; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE; ZIDOVUDINE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA; MALE; PLASMABLASTIC LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; EPSTEIN BARR VIRUS INFECTION; IMMUNOBLASTIC LYMPHOMA; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; LARGE CELL LYMPHOMA; MIDDLE AGED; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PLASMA CELL; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADULT; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN-MEIERS ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; PLASMA CELLS; RETROSPECTIVE STUDIES;

EID: 78049502867     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPJH6KEUSECQLU     Document Type: Article

References (31)

1. Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008. WHO Classification of Tumours; Vol 2.
2. Lennert K. Non-Hodgkin's lymphomas: principles and application of the Kiel classification [in German]. Verh Dtsch Ges Pathol. 1992;76:1-13.
3. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
4. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937-1947.
5. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413-1420.
6. Castillo J, Pantanowitz L, Dezube BJ. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol. 2008;83:804-809.
7. Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736-747. (Pubitemid 38685887)
8. Teruya-Feldstein J, Chiao E, Filippa DA, et al. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol. 2004;15:1673-1679. (Pubitemid 39562609)
9. Deloose ST, Smit LA, Pals FT, et al. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia. 2005;19:851-855.
10. Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol. 2005;29:1633-1641. (Pubitemid 43754485)
11. Balague O, Mozos A, Martinez D, et al. Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications. Am J Pathol. 2009;174:2337-2346.
12. Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005;18:806-815. (Pubitemid 40780514)
13. Kremer M, Ott G, Nathrath M, et al. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J Pathol. 2005;205:92-101.
14. Carbone A, Gaidano G, Gloghini A, et al. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma. Ann Otol Rhinol Laryngol. 1999;108:95-99.
15. Carbone A, Gloghini A. Plasmablastic lymphoma: one or more entities? Am J Hematol. 2008;83:763-764.
16. Nguyen DD, Loo BW Jr, Tillman G, et al. Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol. 2003;82:521-525. (Pubitemid 37062754)
17. Reid-Nicholson M, Kavuri S, Ustun C, et al. Plasmablastic lymphoma: cytologic findings in 5 cases with unusual presentation. Cancer. 2008;114:333-341.
18. Chetty R, Hlatswayo N, Muc R, et al. Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology. 2003;42:605-609. (Pubitemid 36688156)
19. Flaitz CM, Nichols CM, Walling DM, et al. Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol. 2002;38:96-102.
20. Robak T, Urbanska-Rys H, Strzelecka B, et al. Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter's syndrome. Eur J Haematol. 2001;67:322-327.
21. Borenstein J, Pezzella F, Gatter KC. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology. 2007;51:774-777. (Pubitemid 350179408)
22. Rafaniello Raviele P, Pruneri G, Maiorano E. Plasmablastic lymphoma: a review. Oral Dis. 2009;15:38-45.
23. Panos G, Karveli EA, Nikolatou O, et al. Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol. 2007;82:761-765. (Pubitemid 47221664)
24. Lester R, Li C, Phillips P, et al. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma. 2004;45:1881-1885. (Pubitemid 38997157)
25. Raez L, Cabral L, Cai JP, et al. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses. 1999;15:713-719. (Pubitemid 29237394)
26. Aboulafia DM, Ratner L, Miles SA, et al. Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019. Clin Lymphoma Myeloma. 2006;6:399-402.
27. Bogusz AM, Seegmiller AC, Garcia R, et al. Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literature. Am J Clin Pathol. 2009;132:597-605.
28. Dawson MA, Schwarer AP, McLean C, et al. AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation: treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. Haematologica. 2007;92:e11-e12. doi:10.3324/haematol.10933.
29. Chuah KL, Ng SB, Poon L, et al. Plasmablastic lymphoma affecting the lung and bone marrow with CD10 expression and t(8;14)(q24;q32) translocation. Int J Surg Pathol. 2009;17:163-166.
30. Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, et al. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features [published online ahead of print March 26, 2010]. Mod Pathol. 2010;23:991-999.
31. Yotsumoto M, Ichikawa N, Ueno M, et al. CD20-negative CD138-positive leukemic large cell lymphoma with plasmablastic differentiation with an IgH/MYC translocation in an HIV-positive patient. Intern Med. 2009;48:559-562.